- Home
- HTBK vs XNCR Comparison
HTBK vs XNCR Comparison
Compare HTBK & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTBK
- XNCR
- Stock Information
- Founded
- HTBK 1997
- XNCR 1997
- Country
- HTBK United States
- XNCR United States
- Employees
- HTBK N/A
- XNCR N/A
- Industry
- HTBK Major Banks
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- HTBK Finance
- XNCR Health Care
- Exchange
- HTBK Nasdaq
- XNCR Nasdaq
- Market Cap
- HTBK 571.6M
- XNCR 579.3M
- IPO Year
- HTBK 1998
- XNCR 2013
- Fundamental
- Price
- HTBK $9.30
- XNCR $8.54
- Analyst Decision
- HTBK Buy
- XNCR Buy
- Analyst Count
- HTBK 3
- XNCR 7
- Target Price
- HTBK $11.33
- XNCR $27.50
- AVG Volume (30 Days)
- HTBK 410.3K
- XNCR 855.3K
- Earning Date
- HTBK 07-24-2025
- XNCR 08-04-2025
- Dividend Yield
- HTBK 5.60%
- XNCR N/A
- EPS Growth
- HTBK N/A
- XNCR N/A
- EPS
- HTBK 0.68
- XNCR N/A
- Revenue
- HTBK $174,083,000.00
- XNCR $127,228,000.00
- Revenue This Year
- HTBK $7.71
- XNCR N/A
- Revenue Next Year
- HTBK $6.13
- XNCR $28.84
- P/E Ratio
- HTBK $13.68
- XNCR N/A
- Revenue Growth
- HTBK N/A
- XNCR N/A
- 52 Week Low
- HTBK $7.83
- XNCR $7.16
- 52 Week High
- HTBK $11.27
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- HTBK 49.93
- XNCR 44.94
- Support Level
- HTBK $9.11
- XNCR $8.05
- Resistance Level
- HTBK $9.74
- XNCR $10.20
- Average True Range (ATR)
- HTBK 0.16
- XNCR 0.57
- MACD
- HTBK -0.03
- XNCR -0.01
- Stochastic Oscillator
- HTBK 34.33
- XNCR 31.40
About HTBK Heritage Commerce Corp
Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two reportable segments, namely Banking and Factoring. A majority of its revenue is generated from the Banking segment, which provides various loan products, including commercial and industrial loans, commercial real estate loans, construction loans, etc. This segment also focuses on deposit generation on relationship accounts, encompassing non-interest bearing demand, interest bearing demand, money market accounts, certificates of deposit, and savings accounts.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.